Cydulka R, Davison R, Grammer L, Parker M, Mathews J
Section of Emergency Medicine, Northwestern University Medical School, Chicago, Illinois 60611.
Ann Emerg Med. 1988 Apr;17(4):322-6. doi: 10.1016/s0196-0644(88)80772-8.
Three subcutaneous doses of 0.3 mL 1:1,000 epinephrine were given 20 minutes apart to 95 adult asthmatics 15 to 96 years old during 108 asthma exacerbations. Patients with a history of recent myocardial infarction or of angina were excluded from our study. Heart rhythm and rate, blood pressure, respiratory rate, and clinical response were prospectively evaluated before, during, and after the administration of epinephrine. There was no significant difference in the occurrence of ventricular arrhythmias between patients less than 40 and more than 40 years old. The mean systolic and diastolic blood pressures, mean heart rate, and mean respiratory rate decreased with treatment in the older population. Our results suggest that epinephrine is safe to use in acute asthmatics of any age.
在108次哮喘发作期间,对95名年龄在15至96岁的成年哮喘患者皮下注射三次0.3毫升1:1000肾上腺素,每次间隔20分钟。近期有心肌梗死或心绞痛病史的患者被排除在我们的研究之外。在注射肾上腺素之前、期间和之后,对心律、心率、血压、呼吸频率和临床反应进行了前瞻性评估。年龄小于40岁和大于40岁的患者之间室性心律失常的发生率没有显著差异。老年人群的平均收缩压和舒张压、平均心率和平均呼吸频率随着治疗而下降。我们的结果表明,肾上腺素在任何年龄的急性哮喘患者中使用都是安全的。